Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

FDG-SPECT: correlation with FDG-PET

W H Martin1, D Delbeke, J A Patton

  • 1Department of Radiology, Vanderbilt University Medical Center, Nashville, Tennessee 37232-2675, USA.

Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|June 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clark County Medical Society.

Chicago medical examiner·2023
Same author

Various Forms of Intermittent Diseases.

Illinois and Indiana medical and surgical journal·2023
Same author

The impact of common dopamine D2 receptor gene polymorphisms on D2/3 receptor availability: C957T as a key determinant in putamen and ventral striatum.

Translational psychiatry·2017
Same author

Similarities and differences between tau protein and chromobindin A.

Neurochemistry international·2010
Same author

[FDG-PET/CT in oncology. German Guideline].

Nuklearmedizin. Nuclear medicine·2007
Same author

Assessment of tinnitus: measurement of treatment outcomes.

Progress in brain research·2007
Same journal

Overall Survival with [<sup>177</sup>Lu]Lu-PSMA-617 Versus [<sup>177</sup>Lu]Lu-PSMA I&T: A Propensity Score-Matched Real-World Analysis.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026
Same journal

Toward a Biopsy-Free Diagnosis of Prostate Cancer: Potential of Combined <sup>18</sup>F-Flotufolastat PSMA PET and mpMRI.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026
Same journal

PSMA PET/CT-Targeted Biopsy in Men with Negative or Equivocal Multiparametric MRI and Exploratory Dynamic Total-Body PET: The FUPERMAN Study.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026
Same journal

Erratum.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026
Same journal

Live from 2026 SNMMI Annual Meeting in Los Angeles!

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026
Same journal

CAR T-Cell Therapy for Cancer: Updates and Challenges for Response Assessment.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026
See all related articles

Fluorodeoxyglucose-single photon emission computed tomography (FDG-SPECT) offers comparable diagnostic information to FDG-PET for cardiac and oncologic conditions. This less expensive and more accessible imaging technique shows promise for evaluating myocardial viability and diagnosing tumors.

Area of Science:

  • Nuclear Medicine
  • Medical Imaging
  • Oncology
  • Cardiology

Background:

  • Fluorodeoxyglucose-Positron Emission Tomography (FDG-PET) is clinically valuable for cardiac, oncologic, and neurologic diseases.
  • High cost and limited availability are major drawbacks of FDG-PET imaging.

Purpose of the Study:

  • To evaluate the clinical utility of FDG-SPECT imaging using a conventional dual-headed camera.
  • To compare FDG-SPECT with FDG-PET for diagnostic information in patients.
  • To assess FDG-SPECT as a less expensive and more accessible alternative to FDG-PET.

Main Methods:

  • Compared FDG-SPECT and FDG-PET in 21 patients.
  • Assessed image quality using physical parameters and phantom studies.

Related Experiment Videos

  • Utilized 511-keV collimators for FDG-SPECT imaging.

    • Main Results:

    • FDG-SPECT achieved resolution and sensitivity lower than PET but could resolve clinically relevant defects and lesions.
    • FDG-SPECT provided similar diagnostic information for myocardial viability compared to PET in heart disease patients.
    • FDG-SPECT visualized malignant tissue equally well as FDG-PET in most patients; smaller or benign lesions were not visualized.

    Conclusions:

    • FDG-SPECT with 511-keV collimation is a cost-effective, readily available, and simpler alternative to PET.
    • FDG-SPECT demonstrates sufficient sensitivity and resolution for detecting myocardial viability and diagnosing malignant tumors >= 2 cm.